查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713320

2025年全球植入式輸液幫浦市場報告

Implantable Infusion Pumps Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年植入式輸液幫浦市場規模將強勁成長。到 2029 年，這一數字將成長至 268.9 億美元，年複合成長率(CAGR)為 7.0%。預測期內的成長歸因於個人化醫療、遠端患者監護、藥物開發和慢性病管理。預測期內的關鍵趨勢包括微創植入、遠端監控和程式設計、鞘內疼痛管理和多學科合作。

慢性疼痛、癌症和糖尿病等慢性疾病的盛行率不斷上升預計將推動對植入式輸液幫浦的需求。通常使用幫浦來注射藥物來治療這些疾病。由於人口老化和生活方式的改變，全球慢性疾病和殘疾的逐漸增加凸顯了對此類醫療設備的需求。例如，根據美國癌症協會2022年1月發布的報告，預計2022年美國將新增190萬例癌症病例，609,360例癌症死亡病例。此外，估計還有10,470名兒童和5,480名青少年罹患癌症。預計此類慢性疾病的增加將對植入式輸液幫浦市場的成長做出重大貢獻。

預計老齡人口的不斷增加將進一步推動植入式輸液幫浦市場的成長。植入式輸液幫浦廣泛用於治療慢性疾病，因此對於能夠從這些設備中受益的日益成長的老齡化人口來說至關重要。根據世界衛生組織（WHO）2022年10月發布的報告，預計到2030年，全球六分之一的人口將超過60歲，預計2020年至2050年間80歲及以上人口將增加4.26億。預測到2050年，全球將有21億人年齡在60歲或以上，預計人口老化將持續推動植入式輸注幫浦的需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式輸液幫浦 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球植入式輸液幫浦市場：成長率分析
  • 全球植入式輸液幫浦市場表現：規模與成長，2019-2024
  • 全球植入式輸液幫浦市場預測：規模與成長，2024-2029 年，2034 年
  • 植入式輸液幫浦的全球總目標市場（TAM）

第6章市場區隔

  • 全球植入式輸液幫浦市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 病人自控鎮痛（PCA）泵
  • 腸內泵
  • 胰島素幫浦
  • 彈性體泵
  • 注射式幫浦
  • 其他類型
  • 全球植入式輸液幫浦市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 腫瘤學
  • 小兒科或新生兒科
  • 胃腸病學
  • 血液學
  • 糖尿病
  • 其他用途
  • 全球植入式輸液幫浦市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 專科診所
  • 全球植入式輸液幫浦市場依病患自控鎮痛 (PCA) 幫浦類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 氫可酮PCA泵
  • FentanylPCA泵
  • 其他鴉片類藥物PCA泵
  • 全球植入式輸液幫浦市場細分（按腸內幫浦類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 管飼幫浦
  • 基於注射器的腸內泵
  • 定期或間歇供水泵
  • 全球植入式輸液幫浦市場細分（按胰島素幫浦類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 胰島素輸注泵
  • 胰島素貼片幫浦
  • 智慧胰島素泵
  • 全球植入式輸液幫浦市場細分（按彈性幫浦類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 一次性彈性體泵
  • 可重複使用的彈性體泵
  • 全球植入式輸液幫浦市場細分（按注射注射式幫浦類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 小容量注射式幫浦
  • 大容量注射式幫浦
  • 全球植入式輸液幫浦市場，按類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 化療輸液泵
  • 抗生素輸液泵
  • 疼痛管理泵

第7章 區域和國家分析

  • 全球植入式輸液幫浦市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式輸液幫浦市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 植入式輸液幫浦市場：競爭格局
  • 植入式輸液幫浦市場：公司簡介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical, a Smiths Group company
  • Terumo Corporation
  • Johnson & Johnson
  • Greatbatch Medical
  • NeuroPace Inc.
  • Primetech Corporation
  • Flowonix Medical Inc.
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Micrel Medical
  • Insulet Corporation
  • ICU Medical Inc.
  • Becton Dickinson and Company（BD）

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年植入式輸液幫浦市場：提供新機會的國家
  • 2029年植入式輸液幫浦市場：細分市場帶來新機會
  • 2029年植入式輸液幫浦市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r32598

Implantable infusion pumps are advanced drug delivery systems designed to be surgically implanted within a patient's body. These devices are responsible for controlled and precise administration of medication directly into the bloodstream.

The implantable infusion pumps market is categorized into several types, including patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and other variations. For instance, insulin pumps are small devices implanted under the skin during surgical procedures to continuously deliver insulin for patients with diabetes. These implantable infusion pumps find applications across various medical fields, including oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, and more. They are commonly used in healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics to provide effective and precise drug delivery to patients.

The implantable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market statistics, including implantable infusion pumps industry global market size, regional shares, competitors with a implantable infusion pumps market share, detailed implantable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the implantable infusion pumps industry. This implantable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable infusion pumps market size has grown steadily in recent years. It will grow from $19.59 billion in 2024 to $20.48 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to chronic disease management, aging population, pain management, regulatory approvals.

The implantable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $26.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include minimally invasive implantation, remote monitoring and programming, intrathecal pain management, interdisciplinary collaboration.

The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes is anticipated to be a driving force behind the demand for implantable infusion pumps. These pumps are commonly utilized to administer pharmaceutical drugs for treating these ailments. The gradual increase in chronic illnesses and disorders worldwide, primarily attributed to an aging population and shifts in lifestyle, underscores the need for such medical devices. For example, a report published by the American Cancer Society in January 2022 highlighted an anticipated 1.9 million new cancer cases in the US in 2022, with 609,360 projected deaths. An estimated 10,470 pediatric cancer cases and 5,480 teenage cancer diagnoses are also expected. This rise in chronic diseases is projected to significantly contribute to the growth of the implantable infusion pumps market.

The expanding aging population is predicted to further fuel the growth of the implantable infusion pumps market. Implantable infusion pumps are extensively used in the management of chronic conditions, making them crucial for a growing aging demographic that can benefit from these devices. A report by the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally will be 60 or older, while the number of individuals aged 80 or older is estimated to increase by 426 million between 2020 and 2050. With projections indicating 2.1 billion people worldwide aged 60 or older by 2050, the rising aging population will continue to drive the demand for implantable infusion pumps.

Market players in the implantable infusion pump industry are increasingly prioritizing the development of smart infusion pumps. The utilization of wireless technology in healthcare monitoring devices is on the rise, providing improved ease of use, connectivity, and data analysis. Integrating wireless technology allows seamless data transfer from the device to a smartphone or another wireless device using Bluetooth or cellular connections. This facilitates data processing, display, and subsequent analysis for studying the individual's health condition. Moreover, software platforms are being innovated to enable patient monitoring and reduce the occurrence of human error in the process.

Leading companies in the implantable infusion pump market are focusing on the development of new products, such as insulin pumps, to address a broader customer base, boost sales, and increase revenue. Insulin pumps are medical devices designed to assist individuals with diabetes in managing their blood sugar levels. Notably, in April 2023, Medtronic, an Ireland-based medical device company, announced the FDA approval for the MiniMed 780G System featuring meal detection technology. This product distinguishes itself by setting the lowest glucose target (as low as 100 mg/dL) among all automated insulin pumps available in the market, aiming to closely mirror the average glucose levels of individuals without diabetes. The system operates on a treat-to-target basis, automatically making basal insulin adjustments and autocorrections to attain a specific target. Additionally, it stands out as the only pump featuring an infusion set that can be worn comfortably for an extended period of up to 7 days. This extended wear time is facilitated by advanced materials that minimize insulin preservative loss, maintaining consistent insulin flow and stability while reducing the likelihood of infusion set occlusion.

In March 2022, Vygon SAS, a Paris-based manufacturer of medical devices and healthcare solutions, acquired Macatt Medica Peruana SAC for an undisclosed amount. The acquisition aims to bolster Vygon's product portfolio, expand its market reach, integrate innovative technologies, and enhance its competitive position. Macatt Medica Peruana SAC, a Peru-based company, specializes in the development and production of advanced medical devices, with a particular focus on infusion systems for direct medication delivery.

Major companies operating in the implantable infusion pumps market include Medtronic PLC, Boston Scientific Corporation, Nevro Corp, LivaNova PLC, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, NeuroPace Inc., Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Stryker Corporation, Zimmer Biomet Holdings Inc., Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

North America was the largest region in the implantable infusion pumps market in 2024. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The implantable infusion pumps market consists of sales of instruments such as patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Infusion Pumps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable infusion pumps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Patient-Controlled Analgesia (PCA) Pumps; Enteral Pumps; Insulin Pumps; Elastomeric Pumps; Syringe Pumps; Other Types
  • 2) By Applications: Oncology; Pediatrics Or Neonatology; Gastroenterology; Hematology; Diabetes; Other Applications
  • 3) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Subsegments:
  • 1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps; Fentanyl PCA Pumps; Other Opioid PCA Pumps
  • 2) By Enteral Pumps: Tube Feeding Pumps; Syringe-based Enteral Pumps; Continuous Or Intermittent Feeding Pumps
  • 3) By Insulin Pumps: Insulin Delivery Pumps; Insulin Patch Pumps; Smart Insulin Pumps
  • 4) By Elastomeric Pumps: Disposable Elastomeric Pumps; Reusable Elastomeric Pumps
  • 5) By Syringe Pumps: Small Volume Syringe Pumps; Large Volume Syringe Pumps
  • 6) By Other Types: Chemotherapy Infusion Pumps; Antibiotic Infusion Pumps; Pain Management Pumps
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Nevro Corp; LivaNova PLC; Baxter International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Infusion Pumps Market Characteristics

3. Implantable Infusion Pumps Market Trends And Strategies

4. Implantable Infusion Pumps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Infusion Pumps Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Infusion Pumps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Infusion Pumps Market Growth Rate Analysis
  • 5.4. Global Implantable Infusion Pumps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Infusion Pumps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Infusion Pumps Total Addressable Market (TAM)

6. Implantable Infusion Pumps Market Segmentation

  • 6.1. Global Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient-Controlled Analgesia (PCA) Pumps
  • Enteral Pumps
  • Insulin Pumps
  • Elastomeric Pumps
  • Syringe Pumps
  • Other Types
  • 6.2. Global Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Pediatrics Or Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes
  • Other Applications
  • 6.3. Global Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • 6.4. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Morphine PCA Pumps
  • Fentanyl PCA Pumps
  • Other Opioid PCA Pumps
  • 6.5. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Enteral Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tube Feeding Pumps
  • Syringe-based Enteral Pumps
  • Continuous or Intermittent Feeding Pumps
  • 6.6. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Delivery Pumps
  • Insulin Patch Pumps
  • Smart Insulin Pumps
  • 6.7. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Elastomeric Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Elastomeric Pumps
  • Reusable Elastomeric Pumps
  • 6.8. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Syringe Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Volume Syringe Pumps
  • Large Volume Syringe Pumps
  • 6.9. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemotherapy Infusion Pumps
  • Antibiotic Infusion Pumps
  • Pain Management Pumps

7. Implantable Infusion Pumps Market Regional And Country Analysis

  • 7.1. Global Implantable Infusion Pumps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Infusion Pumps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Infusion Pumps Market

  • 8.1. Asia-Pacific Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Infusion Pumps Market

  • 9.1. China Implantable Infusion Pumps Market Overview
  • 9.2. China Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Infusion Pumps Market

  • 10.1. India Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Infusion Pumps Market

  • 11.1. Japan Implantable Infusion Pumps Market Overview
  • 11.2. Japan Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Infusion Pumps Market

  • 12.1. Australia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Infusion Pumps Market

  • 13.1. Indonesia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Infusion Pumps Market

  • 14.1. South Korea Implantable Infusion Pumps Market Overview
  • 14.2. South Korea Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Infusion Pumps Market

  • 15.1. Western Europe Implantable Infusion Pumps Market Overview
  • 15.2. Western Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Infusion Pumps Market

  • 16.1. UK Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Infusion Pumps Market

  • 17.1. Germany Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Infusion Pumps Market

  • 18.1. France Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Infusion Pumps Market

  • 19.1. Italy Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Infusion Pumps Market

  • 20.1. Spain Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Infusion Pumps Market

  • 21.1. Eastern Europe Implantable Infusion Pumps Market Overview
  • 21.2. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Infusion Pumps Market

  • 22.1. Russia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Infusion Pumps Market

  • 23.1. North America Implantable Infusion Pumps Market Overview
  • 23.2. North America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Infusion Pumps Market

  • 24.1. USA Implantable Infusion Pumps Market Overview
  • 24.2. USA Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Infusion Pumps Market

  • 25.1. Canada Implantable Infusion Pumps Market Overview
  • 25.2. Canada Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Infusion Pumps Market

  • 26.1. South America Implantable Infusion Pumps Market Overview
  • 26.2. South America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Infusion Pumps Market

  • 27.1. Brazil Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Infusion Pumps Market

  • 28.1. Middle East Implantable Infusion Pumps Market Overview
  • 28.2. Middle East Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Infusion Pumps Market

  • 29.1. Africa Implantable Infusion Pumps Market Overview
  • 29.2. Africa Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Infusion Pumps Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Infusion Pumps Market Competitive Landscape
  • 30.2. Implantable Infusion Pumps Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Infusion Pumps Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Fresenius Kabi AG
  • 31.3. Smiths Medical, a Smiths Group company
  • 31.4. Terumo Corporation
  • 31.5. Johnson & Johnson
  • 31.6. Greatbatch Medical
  • 31.7. NeuroPace Inc.
  • 31.8. Primetech Corporation
  • 31.9. Flowonix Medical Inc.
  • 31.10. F. Hoffmann-La Roche Ltd
  • 31.11. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.12. Micrel Medical
  • 31.13. Insulet Corporation
  • 31.14. ICU Medical Inc.
  • 31.15. Becton Dickinson and Company (BD)

32. Global Implantable Infusion Pumps Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Infusion Pumps Market

34. Recent Developments In The Implantable Infusion Pumps Market

35. Implantable Infusion Pumps Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Infusion Pumps Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Infusion Pumps Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Infusion Pumps Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer